Dirty Money “Drug Short” episode and thyroid T3 Liothyronine

In the "Dirty Money" series on Netflix, the "Drug Short" episode (1) helped me understand some of the economic forces that may have influenced T3 / Liothyronine price hikes in the UK. It makes me concerned about the future of T3 pricing in Canada too. This episode focuses on Valeant, a Canadian pharmaceutical company that …

Continue reading Dirty Money “Drug Short” episode and thyroid T3 Liothyronine

Free T3 testing reveals autoimmune thyroid damage

The American Thyroid Association prolongs the suffering of patients with autoimmune thyroid damage whose TSH has not yet risen to >10 mIU/L or their Free T4 has not yet fallen below reference. (1, 2) As I will outline in this post, medicine's inability to distinguish "subclinical hypothyroidism" from true hypothyroidism stems from the misguided policy …

Continue reading Free T3 testing reveals autoimmune thyroid damage

Campaign wish list, February 2019

WISH LIST: What our campaign needs (updated February 1. 2019) • Reviews and likes on our Facebook Page at https://www.facebook.com/thyroidpatients.ca/ , 2-way discussion in our public FB Group where you can also add posts, and your engagement in post likes/responses, post shares, and comments. • Real Canadian thyroid patient stories of struggles with the health care system, …

Continue reading Campaign wish list, February 2019